Generate a tailored SOP for Dr. Andrew Marks. Improve your application with a focused, well-structured draft.
Andrew R. Marks, MD, received his undergraduate degree from Amherst College, majoring in Biology and English with honors, and earned his MD from Harvard Medical School in 1980. Following his education, he completed an internship and residency in internal medicine at Massachusetts General Hospital (MGH), where he also pursued post-doctoral fellowships in molecular genetics and clinical cardiology. In 1987, Dr. Marks joined the Cardiology Division at Brigham and Women's Hospital and returned to New York in 1990 as an Assistant Professor of Molecular Biology in Medicine at Mount Sinai School of Medicine. He became the Fishberg Professor of Medicine at Mount Sinai in 1995 and later joined Columbia University Vagelos College of Physicians and Surgeons in 1997, where he currently serves as the Director of the Center for Molecular Cardiology and the Clyde Helen Wu Professor of Medicine Pharmacology. His major research focus is on investigating the molecular mechanisms regulating muscle contraction and calcium signaling in cardiac and skeletal muscle, with implications for understanding heart failure and sudden cardiac death. Dr. Marks has led projects that have paved the way for innovative therapeutics, including drug-eluting stents for coronary artery disease.
Columbia University Vagelos College of Physicians and Surgeons • New York, NY
Director of the Center for Molecular Cardiology and Clyde Helen Wu Professor of Medicine Pharmacology.
PhD programs at VP&S are often administered through the Coordinated Doctoral Programs in Biomedical Sciences (Integrated Program).